ArticleMedical care2020
Disparities in Biomarkers for Patients With Diabetes After the Affordable Care Act.
Article in Medical care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02685384 (Post ACA Reform), which is not on this map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Post ACA Reform: Evaluation of Community Health Center Care of Diabetes
Who cites it
11 citing papers in PubMed, 12 citations in OpenAlex.
- Prevalence of Colorectal Cancer Screening Among Latino Adults Following the Medicaid Eligibility Amendment Expansion.JAMA network open · 2026Article
- The ADVANCE Clinical Research Network Past, Present, and Future: Accelerating Partnerships for Patient-Centered Research in Community-based Primary Care Settings.Medical care · 2026Article
- Medicaid Eligibility Expansion Regardless of Immigration Status and Insurance Coverage Among Latinos Seen in Community Health Centers, 2018‒2023.American journal of public health · 2025Article
- Differences in up-to-date colorectal and cervical cancer screening rates by ethnicity and preferred language: An analysis across patient-, clinic-, and area-level data sources.SSM - population health · 2024Article
- Effect of State-Led Delivery System and Payment Reforms on Population-Level Detection and Management of Diabetes.Diabetes care · 2022Article
- Changes in diabetes prescription patterns following Affordable Care Act Medicaid expansion.BMJ open diabetes research & care · 2021Article
- Patients' Perspective About the Cost of Diabetes Management: An Analysis of Online Health Communities.Mayo Clinic proceedings. Innovations, quality & outcomes · 2021Article
- Achieving Cancer Equity by Improving Health Insurance Access for All Latinos.Journal of primary care & community healthArticle
- The Impact of the Affordable Care Act Medicaid Expansion on Acute Diabetes Complications Among Community Health Center Patients.Journal of primary care & community healthArticle
- The Impact of Medicaid Expansion on Acute Diabetes Complication by Care Delivery Settings.Journal of primary care & community healthArticle
- Diabetes and Hypertension Prevention and Control in Community Health Centers: Impact of the Affordable Care Act.Journal of primary care & community healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundRacial and ethnic minorities are disproportionately affected by diabetes and at greater risk of experiencing poor diabetes-related outcomes compared with non-Hispanic whites. The Affordable Care Act (ACA) was implemented to increase health insurance coverage and reduce health disparities.
objectiveAssess changes in diabetes-associated biomarkers [hemoglobin A1c (HbA1c) and low-density lipoprotein] 24 months pre-ACA to 24 months post-ACA Medicaid expansion by race/ethnicity and insurance group. RESEARCH
designRetrospective cohort study of community health center (CHC) patients. SUBJECTS: Patients aged 19-64 with diabetes living in 1 of 10 Medicaid expansion states with ≥1 CHC visit and ≥1 HbA1c measurement in both the pre-ACA and the post-ACA time periods (N=13,342).
methodsLinear mixed effects and Cox regression modeled outcome measures.
resultsOverall, 33.5% of patients were non-Hispanic white, 51.2% Hispanic, and 15.3% non-Hispanic black. Newly insured Hispanics and non-Hispanic whites post-ACA exhibited modest reductions in HbA1c levels, similar benefit was not observed among non-Hispanic black patients. The largest reduction was among newly insured Hispanics versus newly insured non-Hispanic whites (P<0.05). For the subset of patients who had uncontrolled HbA1c (HbA1c≥9%) within 3 months of the ACA Medicaid expansion, non-Hispanic black patients who were newly insured gained the highest rate of controlled HbA1c (hazard ratio=2.27; 95% confidence interval, 1.10-4.66) relative to the continuously insured group.
conclusionsThe impact of the ACA Medicaid expansion on health disparities is multifaceted and may differ across racial/ethnic groups. This study highlights the importance of CHCs for the health of minority populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.